94.29 USD
-1.74 (-1.81%)
94.29 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to MIRM. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 105.88. This target is 12.29% above the current price.
- MIRM was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MIRM.
- In the previous month the buy percentage consensus was at a similar level.
- MIRM was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-12-19 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-12-16 | Stifel | Maintains | Buy -> Buy |
| 2025-12-09 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-12-09 | Baird | Maintains | Outperform -> Outperform |
| 2025-12-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-05 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-24 | TD Cowen | Initiate | Buy |
| 2025-09-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-11 | Stifel | Reiterate | Buy |
| 2025-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-07 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-13 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-05-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-27 | Baird | Maintains | Outperform -> Outperform |
| 2025-02-24 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-13 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-08 | Baird | Maintains | Outperform -> Outperform |
MIRUM PHARMACEUTICALS INC / MIRM FAQ
Can you provide the average price target for MIRUM PHARMACEUTICALS INC stock?
16 analysts have analysed MIRM and the average price target is 105.88 USD. This implies a price increase of 12.29% is expected in the next year compared to the current price of 94.29.
Can you provide the consensus rating for MIRUM PHARMACEUTICALS INC stock?
The consensus rating for MIRUM PHARMACEUTICALS INC (MIRM) is 86.25 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for MIRM stock?
The number of analysts covering MIRUM PHARMACEUTICALS INC (MIRM) is 16.